Literature DB >> 20326868

Preliminary Survey of 4-Amino-5-Imidazolecarboxamide Excretion in Leukemia and Other Illnesses.

P L McGeer, E G McGeer, R Hasselback.   

Abstract

Entities:  

Year:  1961        PMID： 20326868      PMCID： PMC1848280     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  A general chromatographic survey of aromatic compounds obtained from urine.

Authors:  D M SMITH; R M PAUL; E G McGEER; P L McGEER
Journal:  Can J Biochem Physiol       Date:  1959-12

2.  [Chromatographic method of determination of 5(4)-amino-4(5)-imidazolecarboxamic acid and its content in animal and human urine].

Authors:  A E BRAUNSHTEIN; G Ia VILENKINA
Journal:  Biokhimiia       Date:  1958 Nov-Dec

3.  [Uricemia and urinary excretion of uric acid in the course of acute leukoses].

Authors:  R ARDAILLOU; R SLAMA; G RICHET; J BERNARD
Journal:  Rev Fr Etud Clin Biol       Date:  1960 Jun-Jul

4.  Purine and pyrimidine excretion in normal and leukemic subjects.

Authors:  W S ADAMS; F DAVIS; M NAKATANI
Journal:  Am J Med       Date:  1960-05       Impact factor: 4.965

5.  [Excretion of 5-amino-4-imidazolecarboxamide in human urine].

Authors:  G Ia VILENKINA
Journal:  Vopr Med Khim       Date:  1956 Nov-Dec

6.  A procedure increasing the specificity of the Jaffe reaction for the determination of creatine and creatinine in urine and plasma.

Authors:  H H TAUSSKY
Journal:  Clin Chim Acta       Date:  1956 May-Jun       Impact factor: 3.786

7.  Metabolic studies on histidine, histamine, and related imidazoles.

Authors:  H TABOR
Journal:  Pharmacol Rev       Date:  1954-09       Impact factor: 25.468

8.  Studies on leukemia. I. Uric acid excretion.

Authors:  A A SANDBERG; G E CARTWRIGHT; M M WINTROBE
Journal:  Blood       Date:  1956-02       Impact factor: 22.113
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.